NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
European journal of cancer (Oxford, England : 1990).
Times cited: 136
Poor drug distribution as a possible explanation for the results of the PRECISE trial.
Journal of neurosurgery.
Times cited: 106